Lodoxamide Tromethamine Prevents Neutrophil Accumulation in Reexpansion Pulmonary Edema
- 1 August 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 14 (2) , 227-232
- https://doi.org/10.1097/00005344-198908000-00007
Abstract
Reexpansion pulmonary edema (RPE) is an acute, unilateral lung injury initiated by cytotoxic oxygen metabolites and temporally associated with an influx of polymorphonuclear neutrophils (PMNs); these toxic oxygen products appear to result from reoxygenation of chronically collapsed lung. Lodoxamide tromethamine (U-42585E) reduces infarct size after reperfusion of ischemic myocardium. The possible protective effects of lodoxamide in RPE were examined. Right lungs of rabbits were collapsed for 7 days by injection of air into the pleural space. Reexpansion was accomplished by chest tube with negative pressure in spontaneously ventilating rabbits. Twelve pairs of animals received either lodoxamide (20 mg/kg/h intravenously (i.v.) from 30 min before reexpansion until they were killed) or an equivalent volume of sterile saline. After 2 h, animals were killed by i.v. pentobarbital. Right and left lungs of six pairs of animals were lavaged with 25 ml saline each; the remaining six pairs of animals were studied by measurement of lung wet/dry weight ratio. Albumin concentrations in lavage fluid (BAL) of lodoxamide-treated animals were 243 ± 165 μg/ml in right lung and 29 ± 15 μg/ml in left lung (p < 0.03); albumin concentration in right lung BAL of untreated animals was 1,180 ± 319 μg/ml (p < 0.02 vs. lodoxamide-treated animals). PMN percentages in right BAL (3.8 ± 3.1) and left BAL (2.9 ± 2.2) did not differ in lodoxamide-treated animals (p > 0.65); PMN percentage in right BAL of untreated animals was 18.7 ± 2.9 (p < 0.001 vs. lodoxamide-treated animals). Incubation of PMNs with lodoxamide (1, 10, and 100 μg/ml) resulted in a dose-dependent decrease in directed migration (p < 0.005) but did not affect PMN adherence. Wet/dry weight ratio was not affected by lodoxamide administration. Thus, lodoxamide prevents PMN influx and decreases the alveolar-capillary protein leak in RPE, primarily by inhibiting PMN chemotaxis.This publication has 17 references indexed in Scilit:
- LUNG NEUTROPHILS IN THE ADULT RESPIRATORY-DISTRESS SYNDROME - CLINICAL AND PATHOPHYSIOLOGIC SIGNIFICANCEPublished by Elsevier ,1986
- CHEMOTACTIC ACTIVITY IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH ADULT RESPIRATORY-DISTRESS SYNDROMEPublished by Elsevier ,1985
- ROLE OF LEUKOCYTES IN ACUTE MYOCARDIAL-INFARCTION IN ANESTHETIZED DOGS - RELATIONSHIP TO MYOCARDIAL SALVAGE BY ANTI-INFLAMMATORY DRUGS1984
- Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.Circulation, 1983
- LEUKOCYTE CAPILLARY PLUGGING IN MYOCARDIAL ISCHEMIA AND REPERFUSION IN THE DOG1983
- Reduction of the edema of acute hyperoxic lung injury by granulocyte depletionJournal of Applied Physiology, 1982
- PULMONARY INFLAMMATION DUE TO OXYGEN-TOXICITY - INVOLVEMENT OF CHEMOTACTIC FACTORS AND POLYMORPHONUCLEAR LEUKOCYTESPublished by Elsevier ,1981
- Protective effect of lodoxamide tromethamine on allergen inhalation challengeJournal of Allergy and Clinical Immunology, 1980
- Unilateral pulmonary edema in rabbits after reexpansion of collapsed lungJournal of Applied Physiology, 1979
- Comparative adherence of granulocytes to endothelial monolayers and nylon fiber.Journal of Clinical Investigation, 1978